Literature DB >> 23113487

Topical ivermectin--a step toward making head lice dead lice?

Olivier Chosidow, Bruno Giraudeau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23113487     DOI： 10.1056/NEJMe1211124

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Efficacy and Pharmacokinetics Evaluation of a Single Oral Dose of Afoxolaner against Sarcoptes scabiei in the Porcine Scabies Model for Human Infestation.

Authors:  Charlotte Bernigaud; Fang Fang; Olivier Chosidow; Jacques Guillot; Katja Fischer; Anne Lespine; Ludwig S Aho; Amanda J Mullins; Berhane Tecle; Andrew Kelly; Jean-François Sutra; Francis Moreau; Thomas Lilin; Frédéric Beugnet; Françoise Botterel
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

Review 2.  Paediatrics: how to manage pediculosis capitis.

Authors:  Alexander K C Leung; Joseph M Lam; Kin Fon Leong; Benjamin Barankin; Kam Lun Hon
Journal:  Drugs Context       Date:  2022-03-14

3.  Prospects for Moxidectin as a New Oral Treatment for Human Scabies.

Authors:  Kate E Mounsey; Charlotte Bernigaud; Olivier Chosidow; James S McCarthy
Journal:  PLoS Negl Trop Dis       Date:  2016-03-17

4.  Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model.

Authors:  Charlotte Bernigaud; Fang Fang; Katja Fischer; Anne Lespine; Ludwig Serge Aho; Dominique Dreau; Andrew Kelly; Jean-François Sutra; Francis Moreau; Thomas Lilin; Françoise Botterel; Jacques Guillot; Olivier Chosidow
Journal:  PLoS Negl Trop Dis       Date:  2016-10-12

5.  Survey assessment on pediatricians' attitudes on head lice management.

Authors:  Claudia Fancelli; Manuela Prato; Carlotta Montagnani; Monica Pierattelli; Paolo Becherucci; Elena Chiappini; Maurizio de Martino; Luisa Galli
Journal:  Ital J Pediatr       Date:  2013-10-03       Impact factor: 2.638
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.